Pathogenic variants in the succinate dehydrogenase (SDH) complex are well-established drivers of paragangliomas and pheochromocytomas, and have also been implicated in epithelial neuroendocrine tumors (NETs). The gene discussed is SDHB; the disease is paraganglioma.